SHANGHAI - DROFEN MACHINERY, a premier Turnkey CDMO equipment partner in pharmaceutical packaging and assembly solutions, is excited to introduce its latest advancement: the High-Speed Automatic Assembly Line for Injection Pens. Engineered to revolutionize the production of metabolic and diabetes delivery devices, this state-of-the-art platform offers unparalleled precision, efficiency, and compliance for pharmaceutical manufacturers worldwide.
Driven by our core philosophy to "Make Customer Great Again," this new assembly line ensures seamless, high-volume commercial production while adhering to the most stringent global regulatory standards.
Meeting the Surging Demand for Metabolic Therapies
With the global diabetes epidemic impacting an estimated 537 million adults-and the rapid rise of advanced metabolic biologics for weight management-there is a pressing need for reliable, scalable manufacturing of injection pens [1]. Drofen's Automatic Assembly Line addresses this by automating the entire assembly process, from component integration to final testing, reducing human error and boosting output to meet surging global demand.
Unlike conventional equipment vendors, DROFEN provides a complete Turnkey CDMO solution. This means pharmaceutical companies can rely on a single partner for everything from in-house mold design and component manufacturing to high-speed assembly and final packaging.
Advanced Features of the DROFEN Assembly Platform
Designed with a modular architecture, the system allows customization for various pen designs, including both reusable and disposable models.
Key features include:
•Industry-Leading Production Speed: Utilizing precision robotic arms and servo motors, the line assembles critical components-such as the cartridge holder, piston rod, dose selector knob, and drive mechanism-at a highly stable speed of 160 units per minute (approx. 9,600 units per hour). This ensures tight tolerances and consistent performance, minimizing defects.
•100% In-Line Functional Testing: Equipped with advanced machine vision systems and sensors, the assembly line performs real-time checks for alignment and functionality. Crucially, features like leak detection and torque verification for screw caps are executed without slowing down the 160 units/min output, guaranteeing a 99.9% defect-free yield.
•In-House Tooling & Mold Expertise: A capability most pure machine builders lack, DROFEN designs and fabricates high-precision injection molds in-house. We retain full ownership of the mold design IP on behalf of our clients, ensuring proprietary tooling cannot be replicated by competitors.
•Sterile Environment Compliance: Built to EU GMP Annex 1 and US FDA standards, the line incorporates HEPA-filtered cleanroom integration and isolator technology to prevent contamination. Automated handling reduces touchpoints, making it ideal for sterile pharmaceutical environments.
•Flexible Configuration: The modular setup supports multiple SKUs, with changeover times as low as 20 minutes. This flexibility accommodates different biological formulations, pen sizes, and branding requirements.
Proven Success and Global Expansion
By implementing DROFEN's Turnkey Assembly Line, pharmaceutical companies can significantly accelerate their time-to-market. Recent Factory Acceptance Tests (FAT) with clients across Asia and the Middle East have demonstrated seamless integration and superior reliability.
"Our Automatic Assembly Line represents a leap forward in pharmaceutical automation," stated Jordan Xu, managing director at DROFEN MACHINERY. "But we offer more than just machinery. By integrating mold design, assembly, and our upcoming CRO and GMP compliance services, we are committed to supporting our partners as a true full-chain CDMO partner, ultimately benefiting patients globally."
Expanding Global Footprint
With headquarters in Shanghai, a subsidiary in Singapore (Drofen Team Pte. Ltd.), and a dedicated branch office in India providing 24-48 hour on-site support, DROFEN MACHINERY serves an international clientele across the pharmaceutical and biotechnology sectors.
The new pen assembly line perfectly complements DROFEN's existing high-performance portfolio, including our 300 units/min PFS filling machines and the world's first fully automated PP Syringe Light Inspection Machine (running at 330 units/min).
About DROFEN MACHINERYDROFEN MACHINERY is a globally recognized Turnkey CDMO equipment partner specializing in pharmaceutical manufacturing solutions. From industrial design to commercial production, we empower pharmaceutical companies to scale up faster and compete globally.
Contact:📧 info@drofen-pharma.com📞 +86 189 3004 6646🌐 www.drofen-pharma.com
References[1]: # "International Diabetes Federation. (2021). IDF Diabetes Atlas, 10th edn. Brussels, Belgium."
Related Technical Resources